Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 18138 | 564 | 35.2 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 317 | 3 | HER2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA | 39408 |
| 1927 | 2 | FGF21//FIBROBLAST GROWTH FACTOR//FIBROBLAST GROWTH FACTOR 21 | 5824 |
| 18138 | 1 | SURAMIN//HT 29 D4 CELLS//SURAMIN ANALOGS | 564 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | SURAMIN | authKW | 2811457 | 33% | 28% | 185 |
| 2 | HT 29 D4 CELLS | authKW | 162419 | 1% | 100% | 3 |
| 3 | SURAMIN ANALOGS | authKW | 108279 | 0% | 100% | 2 |
| 4 | 2 2 CARBONYLBISIMINO N METHYL 4 2 PYRROLECARBONYLIMINON METHYL 4 2 PYRROLECARBONYLIMINOBIS 1 5 NAPHTHALENEDIS | authKW | 54140 | 0% | 100% | 1 |
| 5 | 7 7 CARBONYLBISIMINO N METHYL 4 2 PYRROLECARBONYLIMINON METHYL 4 2 PYRROLECARBONYLIMINO BIS1 3 NAPHTHALENEDIS | authKW | 54140 | 0% | 100% | 1 |
| 6 | ACIDIC INTRACELLULAR COMPARTMENT | authKW | 54140 | 0% | 100% | 1 |
| 7 | ADAPTIVE CONTROL WITH FEEDBACK | authKW | 54140 | 0% | 100% | 1 |
| 8 | ADRENAL CORTICAL INSUFFICIENCY | authKW | 54140 | 0% | 100% | 1 |
| 9 | AGAROSE IMMOBILIZATION | authKW | 54140 | 0% | 100% | 1 |
| 10 | AMINONAPHTHALENESULFONIC ACID DERIVATIVES | authKW | 54140 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 2659 | 36% | 0% | 204 |
| 2 | Pharmacology & Pharmacy | 417 | 18% | 0% | 101 |
| 3 | Urology & Nephrology | 242 | 7% | 0% | 38 |
| 4 | Cell Biology | 97 | 9% | 0% | 49 |
| 5 | Chemistry, Medicinal | 49 | 4% | 0% | 20 |
| 6 | Endocrinology & Metabolism | 38 | 4% | 0% | 25 |
| 7 | Biochemistry & Molecular Biology | 37 | 12% | 0% | 65 |
| 8 | Biophysics | 29 | 4% | 0% | 21 |
| 9 | Chemistry, Analytical | 16 | 4% | 0% | 22 |
| 10 | Biochemical Research Methods | 14 | 3% | 0% | 15 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CLIN PHARMACOL BRANCH NIH | 54140 | 0% | 100% | 1 |
| 2 | DIPARTIMENTO SCI ANAT ANIM | 54140 | 0% | 100% | 1 |
| 3 | ENZYMOL INSERM U392 | 54140 | 0% | 100% | 1 |
| 4 | FUNDAMENTALS PHYSIOL PHARMACOL | 54140 | 0% | 100% | 1 |
| 5 | HOSP UNIV MONTREAL CR CHUM | 54140 | 0% | 100% | 1 |
| 6 | INTERDIPARTIMENTALE SISTEMI BIOMOL | 54140 | 0% | 100% | 1 |
| 7 | MED CELL MOLEC BIOL CELL BIOL | 54140 | 0% | 100% | 1 |
| 8 | MENT CLIN BIOCHEM | 54140 | 0% | 100% | 1 |
| 9 | MENT MICROBIOL | 54140 | 0% | 100% | 1 |
| 10 | MICROBIOL PROF PAULO GOES IMPPG BLOCO 1 | 54140 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | EUROPEAN JOURNAL OF CANCER | 1736 | 3% | 0% | 18 |
| 2 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1638 | 3% | 0% | 15 |
| 3 | SECOND MESSENGERS AND PHOSPHOPROTEINS | 900 | 0% | 2% | 1 |
| 4 | CANCER RESEARCH | 833 | 4% | 0% | 25 |
| 5 | AIDS RESEARCH | 806 | 0% | 1% | 1 |
| 6 | PROSTATE | 750 | 1% | 0% | 8 |
| 7 | JOURNAL OF LIQUID CHROMATOGRAPHY | 738 | 1% | 0% | 7 |
| 8 | THEORETICAL SURGERY | 593 | 0% | 1% | 1 |
| 9 | CANCER CELLS-A MONTHLY REVIEW | 562 | 0% | 1% | 1 |
| 10 | JOURNAL OF CLINICAL ONCOLOGY | 544 | 2% | 0% | 13 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | MCGEARY, RP , BENNETT, AJ , TRAN, QB , COSGROVE, KL , ROSS, BP , (2008) SURAMIN: CLINICAL USES AND STRUCTURE-ACTIVITY RELATIONSHIPS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 8. ISSUE 13. P. 1384-1394 | 64 | 62% | 49 |
| 2 | STEIN, CA , (1993) SURAMIN - A NOVEL ANTINEOPLASTIC AGENT WITH MULTIPLE POTENTIAL MECHANISMS OF ACTION.CANCER RESEARCH. VOL. 53. ISSUE 10. P. 2239-2248 | 73 | 68% | 218 |
| 3 | VILLALONA-CALERO, MA , WIENTJES, MG , OTTERSON, GA , KANTER, S , YOUNG, D , MURGO, AJ , FISCHER, B , DEHOFF, C , CHEN, D , YEH, TK , ET AL (2003) PHASE I STUDY OF LOW-DOSE SURAMIN AS A CHEMOSENSITIZER IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER.CLINICAL CANCER RESEARCH. VOL. 9. ISSUE 9. P. 3303-3311 | 52 | 84% | 22 |
| 4 | BAGHDIGUIAN, S , BOUDIER, JL , BOUDIER, JA , FANTINI, J , (1996) INTRACELLULAR LOCALISATION OF SURAMIN, AN ANTICANCER DRUG, IN HUMAN COLON ADENOCARCINOMA CELLS: A STUDY BY QUANTITATIVE AUTORADIOGRAPHY.EUROPEAN JOURNAL OF CANCER. VOL. 32A. ISSUE 3. P. 525-532 | 39 | 95% | 16 |
| 5 | VOOGD, TE , VANSTERKENBURG, ELM , WILTING, J , JANSSEN, LHM , (1993) RECENT RESEARCH ON THE BIOLOGICAL-ACTIVITY OF SURAMIN.PHARMACOLOGICAL REVIEWS. VOL. 45. ISSUE 2. P. 177 -203 | 68 | 45% | 221 |
| 6 | BAGHDIGUIAN, S , FANTINI, J , (1997) SURAMIN: A MOLECULE WITH A BROAD SPECTRUM OF BIOLOGICAL AND THERAPEUTIC PROPERTIES.CANCER JOURNAL - FRANCE. VOL. 10. ISSUE 1. P. 31-37 | 33 | 89% | 17 |
| 7 | OGDEN, A , WIENTJES, MG , AU, JLS , (2004) SURAMIN AS A CHEMOSENSITIZER: ORAL PHARMACOKINETICS IN RATS.PHARMACEUTICAL RESEARCH. VOL. 21. ISSUE 11. P. 2058-2063 | 28 | 85% | 4 |
| 8 | VILLALONA-CALERO, MA , OTTERSON, GA , WIENTJES, MG , WEBER, F , BEKAII-SAAB, T , YOUNG, D , MURGO, AJ , JENSEN, R , YEH, TK , WEI, Y , ET AL (2008) NONCYTOTOXIC SURAMIN AS A CHEMOSENSITIZER IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER: A PHASE II STUDY.ANNALS OF ONCOLOGY. VOL. 19. ISSUE 11. P. 1903 -1909 | 31 | 61% | 18 |
| 9 | LOKSHIN, A , PENG, XJ , CAMPBELL, PG , BARSOUK, A , LEVITT, ML , (1999) MECHANISMS OF GROWTH STIMULATION BY SURAMIN IN NON-SMALL-CELL LUNG CANCER CELL LINES.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 43. ISSUE 4. P. 341-347 | 28 | 88% | 11 |
| 10 | KOSAREK, CE , HU, X , COUTO, CG , KISSEBERTH, WC , GREEN, EM , AU, JLS , WIENTJES, MG , (2006) PHASE I EVALUATION OF LOW-DOSE SURAMIN AS CHEMOSENSITIZER OF DOXORUBICIN IN DOGS WITH NATURALLY OCCURRING CANCERS.JOURNAL OF VETERINARY INTERNAL MEDICINE. VOL. 20. ISSUE 5. P. 1172-1177 | 23 | 82% | 1 |
Classes with closest relation at Level 1 |